Acadia Healthcare Company, Inc. (ACHC)

Acadia Healthcare's stock (ACHC) has experienced a rebound, with gains of approximately 5% over the month and roughly 86% in the past three months as of early May 2026, although it also experienced a 9% decline in the week prior to May 6, 2026. Acadia Healthcare announced strong first-quarter 2026 results on April 29, 2026, beating analyst estimates for both revenue and adjusted EPS. Following these results, Acadia increased its full-year 2026 adjusted EBITDA and adjusted EPS guidance. The company also appointed David Duckworth as interim Chief Financial Officer on April 23, 2026. Earlier in the year, on February 25, 2026, Acadia announced its fourth-quarter and full-year 2025 results.

Demand for behavioral healthcare services exhibits seasonality. Winter peaks are seen for depressive symptoms and bipolar depression admissions. Spring and summer often see peaks in suicidal activity, emergency department (ED) self-harm presentations, and admissions for mania in individuals with bipolar disorder. For children and adolescents, ED visits for mental and behavioral health conditions show seasonal increases during the fall and spring school semesters compared to the summer period. Higher-than-normal temperatures during the summer are also associated with increased ED visits for mental health-related conditions.

Acadia Healthcare Company, Inc. is a prominent American provider of for-profit behavioral healthcare services, operating within the Healthcare sector. Acadia's services include acute inpatient psychiatric facilities, specialty treatment facilities, comprehensive treatment centers (CTCs), residential treatment centers, and outpatient behavioral healthcare services.

Acadia Healthcare operates an extensive network of behavioral healthcare facilities across the United States and Puerto Rico. The company has over 277 facilities located in 40 states and Puerto Rico. In 2024, Acadia operated over 50 inpatient psychiatric hospitals in 19 U.S. states and 165 methadone clinics in 33 states, making it the largest methadone-clinic chain in the U.S.

Acadia Healthcare's reputation has faced challenges. In 2019, the company paid $17 million to resolve allegations of overbilling Medicaid for blood and urine tests. Also in 2019, Acadia shut down its Desert Hills facility in New Mexico after revelations of sexual abuse, subsequently settling five lawsuits related to the abuse. More recently, on February 13, 2025, Acadia Healthcare announced the closure of Timberline Knolls, a mental health treatment facility in Illinois, following multiple allegations of misconduct and legal challenges.

The ownership structure of Acadia Healthcare (ACHC) is predominantly held by institutional investors, including Wellington Management Group Llp, BlackRock, Inc., and Vanguard Group Inc. Significant individual and insider owners include Reeve B. Waud, who is also the founder and chairman, and entities like Waud Capital Partners II LLC and Waud Capital Partners III LLC.